Enhanced TLR-MYD88 Signaling Stimulates Autoinflammation in SH3BP2 Cherubism Mice and Defines the Etiology of Cherubism-Reference-Cited by-同舟云学术

Enhanced TLR-MYD88 Signaling Stimulates Autoinflammation in SH3BP2 Cherubism Mice and Defines the Etiology of Cherubism

Published:2014-09 Issue:6 Volume:8 Page:1752-1766
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Yoshitaka Teruhito,Mukai Tomoyuki,Kittaka Mizuho,Alford Lisa M.,Masrani Salome,Ishida Shu,Yamaguchi Ken,Yamada Motohiko,Mizuno Noriyoshi,Olsen Bjorn R.,Reichenberger Ernst J.,Ueki Yasuyoshi

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference54 articles.

1. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function;Adachi;Immunity,1998

2. Pathogen recognition and innate immunity;Akira;Cell,2006

3. NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism;Aliprantis;J. Clin. Invest.,2008

4. Tankyrase loses its grip on SH3BP2 in cherubism;Berendsen;Cell,2011

5. Cutting Edge: TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption;Burns;J. Immunol.,2006

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced antibacterial properties of enteric glial cells attenuate intestinal inflammation through the GABABR-mediated autophagy pathway;One Health Advances;2024-06-14

2. Echinatin Inhibits Oxidative Stress and Inflammatory Processes in Trophoblast Cells by Inhibiting TLR4-MyD88-NF-κB Pathway in Preeclampsia;Journal of Clinical Pharmacy and Therapeutics;2024-05-20

3. Loss-of-function OGFRL1 variants identified in autosomal recessive cherubism families;JBMR Plus;2024-04-09

4. Scaffold protein SH3BP2 signalosome is pivotal for immune activation in nephrotic syndrome;JCI Insight;2023-12-21

5. Treatment of Progressive Cherubism during the Second Dental Transitional Phase with Calcitonin;Case Reports in Dentistry;2023-11-09